Blanca Espinet
Overview
Explore the profile of Blanca Espinet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
1909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Calvo X, Roman-Bravo D, Garcia-Gisbert N, Rodriguez-Sevilla J, Garcia-Avila S, Florensa L, et al.
Blood Adv
. 2022 Jun;
6(13):3921-3931.
PMID: 35709473
Patients with oligomonocytic chronic myelomonocytic leukemia (OM-CMML) are currently classified according to the 2017 World Health Organization myelodysplastic syndromes classification. However, recent data support considering OM-CMML as a specific subtype...
22.
Garcia-Martin P, Diez A, Maldonado J, Serrano A, Ter Horst R, Benavente Y, et al.
Blood Cancer J
. 2022 May;
12(5):79.
PMID: 35581176
No abstract available.
23.
Baliakas P, Espinet B, Mellink C, Jarosova M, Athanasiadou A, Ghia P, et al.
Hemasphere
. 2022 Apr;
6(4):e707.
PMID: 35392482
Mounting evidence underscores the clinical value of cytogenetic analysis in chronic lymphocytic leukemia (CLL), particularly as it allows the identification of complex karyotype, that has recently emerged as a prognostic...
24.
Garcia-Gisbert N, Garcia-Avila S, Merchan B, Salido M, Fernandez-Rodriguez C, Gibert J, et al.
Blood Adv
. 2022 Feb;
6(10):3178-3188.
PMID: 35192693
Molecular and cytogenetic studies are essential for diagnosis and prognosis in patients with myelodysplastic syndromes (MDSs). Cell-free DNA (cfDNA) analysis has been reported to be a reliable noninvasive approach for...
25.
Chatzikonstantinou T, Kapetanakis A, Scarfo L, Karakatsoulis G, Allsup D, Cabrero A, et al.
Leukemia
. 2021 Nov;
35(12):3444-3454.
PMID: 34725454
Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. We aimed to assess risk factors of outcome...
26.
Costa D, Granada I, Espinet B, Collado R, Ruiz-Xiville N, Puiggros A, et al.
Genes Chromosomes Cancer
. 2021 Aug;
61(1):37-43.
PMID: 34414624
Chromosomal translocations in chronic lymphocytic leukemia (CLL) are very rare, and therefore systematic analysis of large series of cases is needed to allow the identification of recurrent rearrangements, breakpoints involved,...
27.
Vazquez I, Papaleo N, Lop J, Puiggros A, Sanchez-Gonzalez B, Diez-Feijoo R, et al.
Virchows Arch
. 2021 Apr;
479(6):1073-1078.
PMID: 33811533
MYC rearrangements (MYC-R) confer unfavorable prognosis to large B-cell lymphomas (LBCL). Because of the low incidence of such genetic alteration, surrogates to screen MYC-R may be useful in daily practice....
28.
Ramos-Campoy S, Puiggros A, Bea S, Bougeon S, Larrayoz M, Costa D, et al.
Haematologica
. 2021 Mar;
107(3):593-603.
PMID: 33691382
Genome complexity has been associated with poor outcome in patients with chronic lymphocytic leukemia (CLL). Previous cooperative studies established five abnormalities as the cut-off that best predicts an adverse evolution...
29.
Puiggros A, Blanco G, Muntasell A, Rodriguez-Rivera M, Nonell L, Altadill M, et al.
Int J Lab Hematol
. 2021 Feb;
43(5):1032-1040.
PMID: 33615729
Introduction: Dysregulated NK cell-mediated immune responses contribute to tumor evasion in chronic lymphocytic leukemia (CLL), although the NK cell compartment in CLL-like monoclonal B-cell lymphocytosis (MBL) is poorly understood. In...
30.
Blanco G, Puiggros A, Sherry B, Nonell L, Calvo X, Puigdecanet E, et al.
Exp Hematol
. 2021 Jan;
95:68-80.
PMID: 33421548
Several studies in chronic lymphocytic leukemia (CLL) patients have reported impaired immune cell functions, which contribute to tumor evasion and disease progression. However, studies on CLL-like monoclonal B-cell lymphocytosis (MBL)...